FibroBiologics Files Patent Application for Innovative Wound Healing Technology
FibroBiologics, Inc. (Nasdaq: FBLG) has recently submitted a patent application to the United States Patent Office. This application focuses on a groundbreaking use of fibroblast cell-based technology in the development of an adhesive bandage designed specifically for wound healing.
New Possibilities in Wound Care
"Our continuous research into the therapeutic applications of fibroblast cells opens up exciting opportunities for our wound care platform," stated Pete O’Heeron, Founder and CEO of FibroBiologics. "If granted, this patent will enable us to develop a bandage that remains stable at room temperature, making it suitable for use in both post-surgical environments and retail settings."
Revolutionizing Wound Care with Fibroblast Technology
Hamid Khoja, Ph.D., the company’s Chief Scientific Officer, remarked, "We believe that harnessing the unique healing properties of fibroblasts can significantly change the landscape of wound care. By integrating these healing capabilities with a reliable, long-term delivery system, we could make advanced treatments accessible to a broader range of patients."
About FibroBiologics
FibroBiologics is a clinical-stage biotechnology firm dedicated to creating treatments and potential cures for chronic diseases through the use of fibroblast cells and materials derived from them. The company boasts over 160 patents, both granted and pending, across various clinical pathways, including areas such as disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. Their innovative research and technology signify a new chapter in the field of cell therapy.
Contact Information
General Inquiries:
info@fibrobiologics.com
Investor Relations:
Nic Johnson
Russo Partners
212-845-4242
fibrobiologicsIR@russopr.com
Media Contact:
Liz Phillips
Russo Partners
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com
Frequently Asked Questions
What is the focus of FibroBiologics?
FibroBiologics is dedicated to developing therapeutics and potential cures for chronic diseases using fibroblast cells.
What technology does the new patent application cover?
The patent application pertains to the use of fibroblast cell-based technology in adhesive bandages aimed at enhancing wound healing.
How does fibroblast technology benefit wound care?
Fibroblast technology offers unique healing properties that can improve the effectiveness of wound care solutions.
Where is FibroBiologics based?
FibroBiologics is headquartered in Houston.
How many patents does FibroBiologics hold?
FibroBiologics has over 160 patents, both issued and pending, covering a variety of clinical pathways.